F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart

키워드

참고문헌 (73)

1. Sunil M, "Evolving trends in infective endocarditis in a developing country : a consequence of medical progress", Ann Clin Microbiol Antimicrob, 18, pp.43~ (2019)
2. Murillo H, "Infectious diseases of the heart: pathophysiology, clinical and imaging overview", Radiographics, 36, pp.963~983 (2016)
3. Johansen JB, "Infection after pacemaker implantation : infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients", Eur Heart J, 32, pp.991~998 (2011)
4. Li JS, "Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis", Clin Infect Dis, 30, pp.633~638 (2000)
5. Habib G, "2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)", Eur Heart J, 36, pp.3075~3128 (2015)
6. Pizzi MN, "Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography", computed tomography angiography : initial results at an infective endocarditis referral center, 2015, pp.132, 1113~1126
7. Saby L, "Positron emission tomography", computed tomography for diagnosis of prosthetic valve endocarditis : increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion, 2013, pp.61, 2374~2382
8. Dilsizian V, "Adding or selecting imaging modalities for incremental diagnosis : a case study of 18FDG PET", CT in prosthetic valve endocarditis, 2013, pp.6, 1020~1021
9. Dilsizian V, "ASNC imaging guidelines", SNMMI procedure standard for positron emission tomography(PET)nuclear cardiology procedures, 2016, pp.23, 1187~1226
10. Chen W, "Merits of FDG PET", CT and functional molecular imaging over anatomic imaging with echocardiography and CT angiography for the diagnosis of cardiac device infections, 2018, pp.11, 1679~1691
11. Doherty JU, "ACC", AATS, ASE, pp.ASNC, HRS[DOI]
12. Baddour LM, "Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association", Circulation, 132, pp.1435~1486 (2015)
13. Mahmood M, "Meta-analysis of 18F-FDG PET", CT in the diagnosis of infective endocarditis, 2019, pp.26, 922~935
14. Swart LE, "Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography", computed tomography in prosthetic heart valve endocarditis, 2018, pp.138, 1412~1427
15. de Camargo RA, "The role of 18F-fluorodeoxyglucose positron emission tomography", computed tomography in the diagnosis of left-sided endocarditis : native vs prosthetic valves endocarditis, 2020, pp.70, 583~594
16. San S, "Prognostic value of 18F-fluorodeoxyglucose positron emission tomography", computed tomography in infective endocarditis, 2019, pp.74, 1031~1040
17. Kouijzer IJ, "18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis", Nucl Med Commun, 39, pp.747~752 (2018)
18. Kestler M, "Role of(18)F-FDG PET in patients with infectious endocarditis", J Nucl Med, 55, pp.1093~1098 (2014)
19. Kusumoto FM, "2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction", Heart Rhythm, 14, pp.e503~e551 (2017)
20. Athan E, "Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices", JAMA, 307, pp.1727~1735 (2012)
21. Podoleanu C, "Management of cardiac implantable electronic device infection", Arrhythm Electrophysiol Rev, 3, pp.184~189 (2014)
22. Sarrazin JF, "Usefulness of fluorine-18 positron emission tomography", computed tomography for identification of cardiovascular implantable electronic device infections, 2012, pp.59, 1616~1625
23. Juneau D, "Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection : a systematic review and meta-analysis", Circ Cardiovasc Imaging, 10, pp.e005772~ (2017)
24. Mahmood M, "Role of 18F-FDG PET", CT in the diagnosis of cardiovascular implantable electronic device infections : a meta-analysis, 2019, pp.26, 958~970
25. Jiménez-Ballvé A, "Assessment of the diagnostic accuracy of 18F-FDG PET", CT in prosthetic infective endocarditis and cardiac implantable electronic device infection : comparison of different interpretation criteria, 2016, pp.43, 2401~2412
26. Diemberger I, "Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection : a prospective single center study", Eur J Nucl Med Mol Imaging, 46, pp.194~205 (2019)
27. Kadakia S, "Current status of the implantable LVAD", Gen Thorac Cardiovasc Surg, 64, pp.501~508 (2016)
28. Koval CE, "Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients", J Heart Lung Transplant, 33, pp.1164~1172 (2014)
29. Bernhardt AM, "The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections", Eur J Cardiothorac Surg, 51, pp.1072~1077 (2017)
30. Tam MC, "Diagnostic accuracy of FDG PET", CT in suspected LVAD infections: a case series, systematic review, and meta-analysis, 2020, pp.13, 1191~1202
31. Akin S, "18F-FDG PET", CT in the diagnosis and management of continuous flow left ventricular assist device infections : a case series and review of the literature, 2018, pp.64, e11~9
32. Kim J, "FDG PET", CT for early detection and localization of left ventricular assist device infection : impact on patient management and outcome, 2019, pp.12, 722~729
33. de Vaugelade C, "Infections in patients using ventricular-assist devices : comparison of the diagnostic performance of 18F-FDG PET", CT scan and leucocyte-labeled scintigraphy, 2019, pp.26, 42~55
34. Sommerlath Sohns JM, "18F-FDG PET", CT in left-ventricular assist device infection : initial results supporting the usefulness of image-guided therapy, 2020, pp.61, 971~976
35. Kanapinn P, "18F-FDG PET", CT-imaging of left ventricular assist device infection : a retrospective quantitative intrapatient analysis, 2019, pp.26, 1212~1221
36. Dell’Aquila AM, "Fluorine-18 fluorodeoxyglucose positron emission tomography", computed tomography for improving diagnosis of infection in patients on CF-LVAD : longing for more ‘insights’, 2018, pp.19, 532~543
37. Avramovic N, "Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection", Eur J Nucl Med Mol Imaging, 44, pp.1870~1877 (2017)
38. Van Riet J, "(18)F-FDG PET", CT for early detection of embolism and metastatic infection in patients with infective endocarditis, 2010, pp.37, 1189~1197
39. Mikail N, "18F-FDG-PET", CT imaging to diagnose septic emboli and mycotic aneurysms in patients with endocarditis and cardiac device infections, 2018, pp.20, 14~
40. Orvin K, "The role of FDG-PET", CT imaging in early detection of extra-cardiac complications of infective endocarditis, 2015, pp.21, 69~76
41. Nishimura RA, "2014 AHA", ACC guideline for the management of patients with valvular heart disease : executive summary : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
42. Wintenberger C, "Proposal for shorter antibiotic therapies", Med Mal Infect, 47, pp.92~141 (2017)
43. Puerta-Alcalde P, "PET", CT added to Duke criteria facilitates diagnosis and monitoring of long-term suppressive therapy of prosthetic endocarditis, 2017, pp.49, 698~701
44. García JR, "Diagnosis by (18)F-FDG PET", CT of infective endocarditis, staging and monitoring of antibiotic treatment after transposition of surgically corrected great arteries, 2016, pp.35, 115~117
45. Aguadé Bruix S, "Cardiac 18F-FDG PET", CT procedure for the diagnosis of prosthetic endocarditis and intracardiac devices, 2018, pp.37, 163~171
46. Scholtens AM, "Confounders in FDG-PET", CT imaging of suspected prosthetic valve endocarditis, 2016, pp.9, 1462~1465
47. Yoshinaga K, "Imaging myocardial metabolism", Curr Opin Biotechnol, 18, pp.52~59 (2007)
48. Randle PJ, "The glucose fatty-acid cycle : its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus", Lancet, 1, pp.785~789 (1963)
49. Mochizuki T, "FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models", J Nucl Med, 42, pp.1551~1555 (2001)
50. Depre C, "Glucose for the heart", Circulation, 99, pp.578~588 (1999)
51. Osborne MT, "Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation", J Nucl Cardiol, 24, pp.86~99 (2017)
52. Dorbala S, "SNMMI", ASNC, CT and PET, pp.CT 1.0, J Nucl Med[DOI]
53. Kumita S, "Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update : Japanese Society of Nuclear Cardiology recommendations", J Nucl Cardiol, 26, pp.1414~1433 (2019)
54. Asmal AC, "A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects", Br J Clin Pharmacol, 7, pp.531~533 (1979)
55. Persson E, "Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment", Clin Physiol, 10, pp.573~583 (1990)
56. Scholtens AM, "Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging", J Nucl Med, 57, pp.568~573 (2016)
57. Gaeta C, "Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection", Eur J Nucl Med Mol Imaging, 38, pp.2018~2024 (2011)
58. Demeure F, "A randomized trial on the optimization of 18F-FDG myocardial uptake suppression : implications for vulnerable coronary plaque imaging", J Nucl Med, 55, pp.1629~1635 (2014)
59. Caldarella C, "Which is the optimal acquisition time for FDG PET", CT imaging in patients with infective endocarditis, 2013, pp.20, 307~309
60. Scholtens AM, "Dual-time-point FDG PET", CT imaging in prosthetic heart valve endocarditis, 2018, pp.25, 1960~1967
61. Asmar A, "Clinical impact of 18F-FDG-PET", CT in the extra cardiac work-up of patients with infective endocarditis, 2014, pp.15, 1013~1019
62. Slomka PJ, ""Motion-frozen"display and quantification of myocardial perfusion", J Nucl Med, 45, pp.1128~1134 (2004)
63. Pizzi MN, "18F-FDG-PET", CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material, 2017, pp.248, 396~402
64. Balmforth D, "Does positron emission tomography", computed tomography aid the diagnosis of prosthetic valve infective endocarditis, 2016, pp.23, 648~652
65. Mathieu C, "Characterization of 18F-fluorodeoxyglucose uptake pattern in noninfected prosthetic heart valves", Circ Cardiovasc Imaging, 10, pp.e005585~ (2017)
66. Scholtens AM, "FDG PET", CT in prosthetic heart valve endocarditis : there is no need to wait, 2017, pp.24, 1540~1541
67. FDG-PET CT for the evaluation of native valve endocarditis, "J Nucl Cardiol", 2020, ~, https:
68. Ahmed FZ, "Metal artefact reduction algorithms prevent false positive results when assessing patients for cardiac implantable electronic device infection", J Nucl Cardiol, 22, pp.219~220 (2015)
69. Scholtens AM, "Attenuation correction and metal artifact reduction in FDG PET", CT for prosthetic heart valve and cardiac implantable device endocarditis, 2018, pp.25, 2172~2173
70. Scholtens AM, "Standardized uptake values in FDG PET", CT for prosthetic heart valve endocarditis : a call for standardization, 2018, pp.25, 2084~2091
71. Hyafil F, "Quantification of FDG uptake in patients with a suspicion of prosthetic valve endocarditis : part of the problem or part of the solution", J Nucl Cardiol, 25, pp.2092~2095 (2018)
72. Rousset O, "Partial volume correction strategies in PET", PET Clin, 2, pp.235~249 (2007)
73. Salavati A, "Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions", Mol Imaging Biol, 17, pp.140~148 (2015)

관련 논문AI추천